New Launch4 Sept 2025, 07:12 pm
Aarti Drugs Ltd Commences Commercial Operations at New Manufacturing Plant in Sayakha
AI Summary
Aarti Drugs Ltd has started commercial production at its new manufacturing plant located in Sayakha, Gujarat, as of September 4, 2025. The company has invested around Rs. 220 Crores for this new facility through a combination of term loans and internal accruals. The plant has an initial proposed capacity of 60 MTPd and will cater to the domestic market with products such as Dimethylamine (DMA), Monomethylamine (MMA), and Trimethylamine (TMA), and their derivatives. The plant is expected to reach full operational capacity within 12 to 18 months, aiming to reduce reliance on external raw materials, enhance supply chain reliability, and drive margin expansion for sustained success in the future.
Key Highlights
- Aarti Drugs Ltd commences commercial production at new Sayakha plant
- Investment of approximately Rs. 220 Crores for the new facility
- Initial proposed capacity of 60 MTPd
- Products include Dimethylamine (DMA), Monomethylamine (MMA), and Trimethylamine (TMA) and derivatives
- Plant to become fully operational within 12 to 18 months, targeting domestic demand